SavedAdd your journal

Journals / Eskisehir Medical Journal / 2026 / Volume: 3 Issue: 2

Clinical Significance of the Relationship Between D-dimer and Erythrocyte Distribution Width in Covid-19 Patients

Covid-19 Hastalarında D-dimer ve Eritrosit Dağılım Genişliği Arasındaki İlişkinin Klinik Önemi

Mustafa Karagülle(ESKİŞEHİR YUNUSEMRE DEVLET HASTANESİ HEMATOLOJİ)0000-0003-4184-902X
Pages
—
Publication Date
2022-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results indicated that high RDW values in patients with COVID-19 disease could be used as a marker in clinical follow-up of patients as D-dimer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Red cell distribution width (RDW) is a marker that can be used in the presence of systemic inflammation and evaluating thromboembolic condition.We aimed to evaluate the relationship between RDW and the level of D-dimer known as related to adverse events in Coronavirus disease 2019 (COVID-19) in this study.
📊
Key Findings & Data:Methods: One hundred twenty two patients with COVID-19 and 62 healthy individuals with age and sex-matched were enrolled in the present study.
💡
Conclusion & Impact:Conclusion: The results indicated that high RDW values in patients with COVID-19 disease could be used as a marker in clinical follow-up of patients as D-dimer.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:red cell distribution witdh · D-dimer · marker

Abstract

Introduction: Red cell distribution width (RDW) is a marker that can be used in the presence of systemic inflammation and evaluating thromboembolic condition.We aimed to evaluate the relationship between RDW and the level of D-dimer known as related to adverse events in Coronavirus disease 2019 (COVID-19) in this study. Methods: One hundred twenty two patients with COVID-19 and 62 healthy individuals with age and sex-matched were enrolled in the present study. The patients were divided into two groups based on evaluating their D-dimer level. The first group contained 45 patients with higher D-dimer level whereas the second group contained 77 patients with normal D-dimer level. Results: RDWvalues were found to be higher in patients with COVID-19 and higher D-dimer level than patients with normal D-dimer level and control group. These results were found to be statistically significant (P=0.006 and P=0.013, respectively). Among patients with COVID-19, a positive correlation was observed between RDW and D-dimer level (r=0.270, P=0.003). Among the various variables associated with higher D-dimer in multivariate logistic regression analyses, RDW detected an independent predictor of higher D-dimer in COVID-19 patients (95% CI: CI:0.322-0.979, P=0.042). Conclusion: The results indicated that high RDW values in patients with COVID-19 disease could be used as a marker in clinical follow-up of patients as D-dimer.

Özet

Giriş: Eritrosit dağılım genişliği (RDW), sistemik inflamasyon varlığında ve tromboembolik durumu değerlendirmede kullanılabilen bir belirteçtir. Bu çalışmada, Coronavirus hastalığı 2019'da (COVID-19) advers olaylarla ilişkili olduğu bilinen D-dimer düzeyi ile RDW arasındaki ilişkiyi değerlendirmeyi amaçladık. Yöntemler: Bu çalışmaya yaş ve cinsiyet açısından uyumlu 122 COVID-19'lu hasta ve 62 sağlıklı birey dahil edildi. Hastalar D-dimer düzeylerinin değerlendirilmesine göre iki gruba ayrıldı. Birinci grup D-dimer düzeyi daha yüksek olan 45 hastayı, ikinci grup ise normal D-dimer düzeyi olan 77 hastayı içeriyordu. Bulgular: D-dimer düzeyi yüksek olan Covid-19 hastalarındaki RDW değerleri, D-dimer düzeyi normal olan Covid-19 hastaları ve kontrol grubuna göre daha yüksek bulundu. Bu sonuçlar istatistiksel olarak anlamlıydı (sırasıyla P=0,006 ve P=0,013). COVID-19 hastaları arasında RDW ile D-dimer düzeyi arasında pozitif bir korelasyon gözlendi (r=0.270, P=0.003). Çok değişkenli lojistik regresyon analizlerinde yüksek D-dimer ile ilişkili çeşitli değişkenler arasında RDW’nin, D-dimerin yüksek olduğu Covid-19 hastalarında bağımsız bir belirteç olduğu saptandı (%95 CI: CI: CI:0.322-0.979, P=0.042). Sonuç: Sonuçlar, COVID-19 hastalığı olan hastalarda yüksek RDW değerlerinin D-dimer gibi hastaların klinik takibinde bir belirteç olarak kullanılabileceğini göstermiştir

🔖

Cite This Article

Karagülle, M. (2022). Clinical Significance of the Relationship Between D-dimer and Erythrocyte Distribution Width in Covid-19 Patients. Eskisehir Medical Journal, Volume: 3 Issue: 2. https://ajindex.com/articles/1614390

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (29)

  1. References 1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497–506.
  2. Tu Y-F, Chien C-S, Yarmishyn AA, et al. A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Int J Mol Sci. 2020 Apr 10;21(7):2657.
  3. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–33.
  4. Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit Care Med. 2020 May 27;Publish Ah.
  5. Beun R, Kusadasi N, Sikma M, Westerink J, Huisman A. Thromboembolic events and apparent heparin resistance in patients infected with SARS‐CoV‐2. Int J Lab Hematol. 2020 Jun 15;42(S1):19–20.
  6. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438–40.
  7. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003 Sep 25;349(13):1227–35.
  8. Frater JL, Zini G, D’Onofrio G, Rogers HJ. COVID‐19 and the clinical hematology laboratory. Int J Lab Hematol. 2020 Jun 15;42(S1):11–8.
  9. Uslu AU, Yonem O, Aydin B, et al. Red cell distribution width is associated with albuminuria in adults with familial Mediterranean fever. Kaohsiung J Med Sci. 2016;32(4):216–20.
  10. Ozsu S, Abul Y, Gunaydin S, Orem A, Ozlu T. Prognostic Value of Red Cell Distribution Width in Patients With Pulmonary Embolism. Clin Appl Thromb Hemost. 2014 May 8;20(4):365–70.
  11. Pehlivanlar Küçük M, Öztuna F, Abul Y, et al. Prognostic value of red cell distribution width and echocardiographic parameters in patients with pulmonary embolism. Adv Respir Med. 2019 Apr 30;87(2):69–76.
  12. Sunnetcioglu A, Sertogullarindan B, Ozbay B, Asker S, Ekin S. Assessments of the associations of thrombus localization with accompanying disorders, risk factors, D-dimer levels, and the red cell distribution width in pulmonary embolism. Clin (Sao Paulo). 2015 Jun 24;70(6):441–5.
  13. Celik A, Ozcan IT, Gündes A, et al. Usefulness of admission hematologic parameters as diagnostic tools in acute pulmonary embolism. Kaohsiung J Med Sci. 2015 Mar;31(3):145–9.
  14. Pan F, Yang L, Li Y, et al. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. Int J Med Sci. 2020;17(9):1281–92.
  15. Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 Jun 4;135(23):2033–40.
  16. Kollias A, Kyriakoulis KG, Dimakakos E, et al. Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action. Br J Haematol. 2020 Jun 4;189(5):846–7.
  17. Zhang L, Yan X, Fan Q, et al. D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19. J Thromb Haemost. 2020 Jun 4;18(6):1324–9.
  18. Eichinger S, Minar E, Bialonczyk C, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA [Internet]. 2003 Aug 27;290(8):1071–4.
  19. García Suquia A, Alonso-Fernández A, de la Peña M, et al. High D-dimer levels after stopping anticoagulants in pulmonary embolism with sleep apnoea. Eur Respir J. 2015 Dec;46(6):1691–700.
  20. Hasegawa M, Wada H, Yamaguchi T, et al. The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE. Clin Appl Thromb Hemost. 2018 May 8;24(4):655–62.
  21. Tamburello A, Bruno G, Marando M. COVID-19 and Pulmonary Embolism: Not a Coincidence. Eur J Case Rep Intern Med. 2020;7(6):001692.
  22. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur Hear J. 2020 May 14;41(19):1858–1858.
  23. Poggiali E, Bastoni D, Ioannilli E, Vercelli A, Magnacavallo A. Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia? Eur J Case Rep Intern Med. 2020 Apr 8;7(5):1.
  24. Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19. J Med Virol. 2020 Jul 10;92(7):791–6.
  25. Leonard-Lorant I, Delabranche X, Severac F, et al. Acute Pulmonary Embolism in COVID-19 Patients on CT Angiography and Relationship to D-Dimer Levels. Radiology. 2020 Apr 23;201561.
  26. Uslu AU, Aydin B, Inal S, et al. The relationship between red cell distribution width and homozygous M694V mutation in familial Mediterranean fever patients. Ann Saudi Med. 2015 Mar;35(2):151–6.
  27. Shahrbanoo Kheirkham-Sabetghadam, Yaser Jenab, Seyed-Mohammad Ghoreyshi-Hefzabad, et al. Association between elevated red blood cell distribution width and long-term mortality in acute pulmonary embolism. Turk J Med Sci. 2018 Apr 30;48(2).
  28. Yčas JW, Horrow JC, Horne BD. Persistent increase in red cell size distribution width after acute diseases: A biomarker of hypoxemia? Clin Chim Acta. 2015 Aug;448:107–17.
  29. Bulut C, Kato Y. Epidemiology of COVID-19. Turk J Med Sci. 2020 Apr 21;50(SI-1):563–70.